Literature DB >> 16529935

Synthesis and in vivo evaluation of [11C]SN003 as a PET ligand for CRF1 receptors.

J S Dileep Kumar1, Vattoly J Majo, Gregory M Sullivan, Jaya Prabhakaran, Norman R Simpson, Ronald L Van Heertum, J John Mann, Ramin V Parsey.   

Abstract

Synthesis and evaluation of [O-methyl-11C](4-methoxy-2-methylphenyl)[1-(1-methoxymethylpropyl)-6-methyl-1H-[1,2,3]triazolo[4,5-c]pyridin-4-yl]amine or [11C]SN003 ([11C]6), as a PET imaging agent for CRF1 receptors, in baboons is described. 4-[1-(1-Methoxymethylpropyl)-6-methyl-1H-[1,2,3]triazolo[4,5-c]pyridin-4-ylamino]-3-methylphenol (5), the precursor molecule for the radiolabeling, was synthesized from 2,4-dichloro-6-methyl-3-nitropyridine in seven steps with 20% overall yield. The total time required for the synthesis of [11C]SN003 is 30 min from EOB using [11C]methyl triflate in the presence of NaOH in acetone. The yield of the synthesis is 22% (EOS) with >99% chemical and radiochemical purities and a specific activity of >2000 Ci/mmol. PET studies in baboon show that [11C]6 penetrates the BBB and accumulates in brain. No detectable specific binding was observed, likely due to the rapid metabolism or low density of CRF1 receptors in primate brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16529935     DOI: 10.1016/j.bmc.2006.02.019

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Dose-dependent effects of the CRF(1) receptor antagonist R317573 on regional brain activity in healthy male subjects.

Authors:  Mark E Schmidt; Randolph D Andrews; Peter van der Ark; Terry Brown; Erik Mannaert; Thomas Steckler; Jan de Hoon; Koen Van Laere
Journal:  Psychopharmacology (Berl)       Date:  2009-11-13       Impact factor: 4.530

2.  Failed PET Application Attempts in the Past, Can We Avoid Them in the Future?

Authors:  Gang Cheng; Thomas J Werner; Andrew Newberg; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

3.  Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor.

Authors:  Jeffrey S Stehouwer; Matthew S Birnbaum; Ronald J Voll; Michael J Owens; Susan J Plott; Chase H Bourke; Michael A Wassef; Clinton D Kilts; Mark M Goodman
Journal:  Bioorg Med Chem       Date:  2015-06-19       Impact factor: 3.641

4.  Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors.

Authors:  Nicholas J Lodge; Yu-Wen Li; Frederick T Chin; Douglas D Dischino; Sami S Zoghbi; Jeffrey A Deskus; Ronald J Mattson; Masao Imaizumi; Rick Pieschl; Thaddeus F Molski; Masahiro Fujita; Heidi Dulac; Robert Zaczek; Joanne J Bronson; John E Macor; Robert B Innis; Victor W Pike
Journal:  Nucl Med Biol       Date:  2014-03-29       Impact factor: 2.408

Review 5.  Corticotropin releasing hormone and imaging, rethinking the stress axis.

Authors:  Carlo Contoreggi
Journal:  Nucl Med Biol       Date:  2014-11-26       Impact factor: 2.408

6.  PET Imaging of CRF1 with [11C]R121920 and [11C]DMP696: is the target of sufficient density?

Authors:  Gregory M Sullivan; Ramin V Parsey; J S Dileep Kumar; Victoria Arango; Suham A Kassir; Yung-Yu Huang; Norman R Simpson; Ronald L Van Heertum; J John Mann
Journal:  Nucl Med Biol       Date:  2007-03-30       Impact factor: 2.408

7.  Synthesis, binding affinity, radiolabeling, and microPET evaluation of 4-(2-substituted-4-substituted)-8-(dialkylamino)-6-methyl-1-substituted-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-ones as ligands for brain corticotropin-releasing factor type-1 (CRF1) receptors.

Authors:  Jeffrey S Stehouwer; Chase H Bourke; Michael J Owens; Ronald J Voll; Clinton D Kilts; Mark M Goodman
Journal:  Bioorg Med Chem Lett       Date:  2015-10-08       Impact factor: 2.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.